Le Lézard
Classified in: Health, Business
Subjects: WOM, AVO, DEI

Fibroid Coalition Says CMS Cut Will Result In Unnecessary Hysterectomies


ATLANTA, Nov. 4, 2021 /PRNewswire-PRWeb/ -- Today, the Fibroid Coalition responded to this week's CMS announcement that will impose a 21% cut to the Physician Fee Schedule. The drastic cut will adversely affect radiologists who perform UFE and the women they treat for fibroids because the end result is out-patient centers being forced to close their doors.

The Fibroid Coalition believes that this round of cuts will undermine the Biden Administration's attempts to close the racial equity gap that exists in healthcare and will reduce options for women suffering from fibroids, leaving them with no choice but to get a hysterectomy.

Since fibroids disproportionately affect women of color, this will add to a growing list of health disparities in an already underserved population. Furthermore, the closing of out-patient centers will lead to greater disparity and decreased care to minority communities.

Dr. John Lipman, the founder of the Fibroid Coalition, said, "The 21% cut was not necessary and will undermine quality of care for patients. Budget neutrality has a place in federal spending policy but this isn't it. Sadly, it means that more women are likely to receive an unnecessary hysterectomy. This decision will increase costs for our health care system and cut off access to a non-surgical treatment option for women suffering from fibroids. Congress must act immediately to reverse these cuts and support women suffering from fibroids."

Media Contact

Dr. John Lipman, Free From Fibroids Foundation, +1 (202) 552-1708, [email protected]

 

SOURCE Fibroid Coalition


These press releases may also interest you

at 13:00
"I'm a Registered Nurse, and I thought there should be a new under bed pad to absorb urine and keep it away from the patient's skin," said an inventor, from Rosedale, N.Y., "so I invented the HUNTER PAD. My design would also provide a cushion for...

at 12:50
ARCpoint Inc. (the "Company" or "ARCpoint") is pleased to announce that it intends to complete a non-brokered private placement to raise gross proceeds of up to C$1,500,000, (the "Offering") through the sale of up to 20,000,000, subordinate voting...

at 12:09
AusperBio Therapeutics, Inc. and Ausper Biopharma Co., Ltd. (collectively AusperBio), a clinical-stage biotechnology company dedicated to advancing targeted oligonucleotide therapies, with the goal of achieving functional cure for chronic hepatitis B...

at 12:05
The "Stem Cell Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. This report contains a comprehensive listing of 162 stem cell deals announced since 2016 including financial terms where...

at 11:40
Neuranics, a deep tech startup headquartered in Glasgow, proudly announces its award for Deep Tech Investment of the Year at the UK Angel Investment Awards held on Wednesday night at a glittering ceremony in the Science Museum London. This award...

at 11:25
The "Asia-Pacific Clinical Biomarkers Market - Analysis and Forecast, 2023-2033" report has been added to ResearchAndMarkets.com's offering. The Asia-Pacific clinical biomarkers market was valued at $3.28 billion in 2023 and is expected to reach...



News published on and distributed by: